Evolus

EOLSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$544.916 M

$8.25 +3.25%

Close of 22 Sept 2026

Revenue

$297.2M

#2135 by revenue

Earnings

-$51.6M

Loss-making

Shares outstanding

66,050,440

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#200Evotec SEEVO$562.1M
#201ArvinasARVN$556.4M
#202EvolusEOLS$544.9M
#203Capricor TherapeuticsCAPR$543.0M
#204Ovid TherapeuticsOVID$539.0M

What if Evolus were worth as much as…

Open the what-if tool →

Gold $30.2T

$457,740.63

Per share 55,484× higher

Bitcoin $1.74T

$26,368.56

Per share 3,196× higher

Nvidia $5.52T

$83,508.41

Per share 10,122× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Evolus are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.